TY  - RPRT
TI  - MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia
AU  - Lerma Clavero, A.
AU  - Lafqvist Boqvist, P.
AU  - Ingelshed, K.
AU  - Bosdotter, C.
AU  - Sedimbi, S.
AU  - Jiang, L.
AU  - Wermeling, F.
AU  - Vojtesek, B.
AU  - Lane, D. P.
AU  - Kannan, P.
PY  - 2022
DO  - 10.1101/2022.10.20.513039
UR  - https://www.biorxiv.org/content/10.1101/2022.10.20.513039v1
ID  - 10.1101/2022.10.20.513039
ER  -